Cargando…

Characterization of antibodies induced by vaccination with Hepatitis C virus envelope glycoproteins

Hepatitis C virus (HCV) envelope glycoproteins E1 and E2 were used with MF59 adjuvant as a candidate vaccine for a phase 1 safety and immunogenicity trial. Ten of 41 vaccinee serum samples displayed a neutralization titer of ⩾1:20 against vesicular stomatitis virus (VSV)-HCV pseudotype, 15 of 36 ser...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ray, Ranjit, Meyer, Keith, Banerjee, Arup, Basu, Arnab, Coates, Stephen, Abrignani, Sergio, Houghton, Michael, Frey, Sharon E., Belshe, Robert B.
Formato:	Texto
Lenguaje:	English
Publicado:	University Chicago Press 2010
Materias:	Major Articles and Brief Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931414/ https://www.ncbi.nlm.nih.gov/pubmed/20677942 http://dx.doi.org/10.1086/655902

Ejemplares similares

A Weak Neutralizing Antibody Response to Hepatitis C Virus Envelope Glycoprotein Enhances Virus Infection
por: Meyer, Keith, et al.
Publicado: (2011)

A Hepatitis C Virus (HCV) Vaccine Comprising Envelope Glycoproteins gpE1/gpE2 Derived from a Single Isolate Elicits Broad Cross-Genotype Neutralizing Antibodies in Humans
por: Law, John Lok Man, et al.
Publicado: (2013)

Cross-Reactive Antibodies With the Capacity to Mediate HIV-1 Envelope Glycoprotein–Targeted Antibody-Dependent Cellular Cytotoxicity Identified in HIV-2–Infected Individuals
por: Karlsson, Ingrid, et al.
Publicado: (2019)

Identification of Aptamer-Binding Sites in Hepatitis C Virus Envelope Glycoprotein E2
por: Chen, Fan, et al.
Publicado: (2015)

Fine Mapping the Interaction Between Dendritic Cell-Specific Intercellular Adhesion Molecule (ICAM)-3-Grabbing Nonintegrin and the Cytomegalovirus Envelope Glycoprotein B
por: Chéneau, Coraline, et al.
Publicado: (2018)

Oncogenic Potential of Hepatitis C Virus Proteins
por: Banerjee, Arup, et al.
Publicado: (2010)

Transient Liver Damage and Hemolysis Are Associated With an Inhibition of Ebola Virus Glycoprotein-Specific Antibody Response and Lymphopenia
por: Fausther-Bovendo, Hugues, et al.
Publicado: (2021)

Maternal Envelope gp41 Ectodomain-Specific Antibodies Are Associated With Increased Mother-to-Child Transmission of Human Immunodeficiency Virus-1
por: Naiman, Nicole E, et al.
Publicado: (2020)

Envelope Glycoprotein of Arenaviruses
por: Burri, Dominique J., et al.
Publicado: (2012)

Intranasal M2SR (M2-Deficient Single Replication) H3N2 Influenza Vaccine Provides Enhanced Mucosal and Serum Antibodies in Adults
por: Eiden, Joseph, et al.
Publicado: (2022)

Stabilizing HIV-1 envelope glycoprotein trimers to induce neutralizing antibodies
por: Torrents de la Peña, Alba, et al.
Publicado: (2018)

Structure of the Core Ectodomain of the Hepatitis C Virus Envelope Glycoprotein 2
por: Khan, Abdul Ghafoor, et al.
Publicado: (2014)

The Neutralizing Face of Hepatitis C Virus E2 Envelope Glycoprotein
por: Tzarum, Netanel, et al.
Publicado: (2018)

Computational Modeling of Hepatitis C Virus Envelope Glycoprotein Structure and Recognition
por: Guest, Johnathan D., et al.
Publicado: (2018)

Membrane Glycoproteins of Enveloped Viruses
por: Compans, Richard W., et al.
Publicado: (1978)

Levels of Antibodies to Hepatitis B Core Antigen Are Associated With Liver Inflammation and Response to Peginterferon in Patients With Chronic Hepatitis B
por: Brakenhoff, Sylvia M, et al.
Publicado: (2022)

Clearance of Genotype 1b Hepatitis C Virus in Chimpanzees in the Presence of Vaccine-Induced E1-Neutralizing Antibodies
por: Verstrepen, Babs E., et al.
Publicado: (2011)

P-Glycoprotein–Mediated Efflux Reduces the In Vivo Efficacy of a Therapeutic Targeting the Gastrointestinal Parasite Cryptosporidium
por: Arnold, Samuel L M, et al.
Publicado: (2019)

Comparison of Rapid Point-of-Care Tests for Detection of Antibodies to Hepatitis C Virus
por: Fisher, Dennis G., et al.
Publicado: (2015)

Association of the Sialylation of Antibodies Specific to the HCV E2 Envelope Glycoprotein with Hepatic Fibrosis Progression and Antiviral Therapy Efficacy
por: Kurtenkov, Oleg, et al.
Publicado: (2020)

Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged 50 Years or Older
por: Cunningham, Anthony L, et al.
Publicado: (2018)

Antibody-dependent cellular cytotoxicity, infected cell binding and neutralization by antibodies to the SIV envelope glycoprotein
por: Grunst, Michael W., et al.
Publicado: (2023)

Genetic Signatures in the Envelope Glycoproteins of HIV-1 that Associate with Broadly Neutralizing Antibodies
por: Gnanakaran, S., et al.
Publicado: (2010)

Antibody-induced internalisation of retroviral envelope glycoproteins is a signal initiation event
por: Panova, Veera, et al.
Publicado: (2020)

Hepatitis C Virus Envelope Glycoproteins: A Balancing Act of Order and Disorder
por: Yost, Samantha A., et al.
Publicado: (2018)

Safety and Immunogenicity of DNA Vaccines Encoding Ebolavirus and Marburgvirus Wild-Type Glycoproteins in a Phase I Clinical Trial
por: Sarwar, Uzma N., et al.
Publicado: (2015)

Long-term Antibody Persistence After Hepatitis E Virus Infection and Vaccination in Dongtai, China
por: Kmush, Brittany L, et al.
Publicado: (2019)

Seroprevalence of anti‐myelin oligodendrocyte glycoprotein antibodies in adults with myelitis
por: Kim, Ki Hoon, et al.
Publicado: (2022)

Envelope glycoprotein interactions in coronavirus assembly
Publicado: (1995)

HCMV Envelope Glycoprotein Diversity Demystified
por: Foglierini, Mathilde, et al.
Publicado: (2019)

Signatures of V(H)1-69-derived hepatitis C virus neutralizing antibody precursors defined by binding to envelope glycoproteins
por: Capella-Pujol, Joan, et al.
Publicado: (2023)

M2-Deficient Single-Replication Influenza Vaccine–Induced Immune Responses Associated With Protection Against Human Challenge With Highly Drifted H3N2 Influenza Strain( )
por: Eiden, Joseph, et al.
Publicado: (2021)

Antibodies against the Envelope Glycoprotein Promote Infectivity of Immature Dengue Virus Serotype 2
por: da Silva Voorham, Júlia M., et al.
Publicado: (2012)

Disassembly of HIV envelope glycoprotein trimer immunogens is driven by antibodies elicited via immunization
por: Turner, Hannah L., et al.
Publicado: (2021)

Immunotherapy-induced antibodies to endogenous retroviral envelope glycoprotein confer tumor protection in mice
por: Kang, Byong H., et al.
Publicado: (2021)

HIV-1 Envelope Glycoprotein Cell Surface Localization Is Associated with Antibody-Induced Internalization
por: Anand, Sai Priya, et al.
Publicado: (2021)

Disassembly of HIV envelope glycoprotein trimer immunogens is driven by antibodies elicited via immunization
por: Turner, Hannah L., et al.
Publicado: (2021)

Epitope-Specific Humoral Responses to Human Cytomegalovirus Glycoprotein-B Vaccine With MF59: Anti-AD2 Levels Correlate With Protection From Viremia
por: Baraniak, Ilona, et al.
Publicado: (2018)

Immunogenicity and functional characterization of Leishmania-derived hepatitis C virus envelope glycoprotein complex
por: Grzyb, Katarzyna, et al.
Publicado: (2016)

Probing the antigenicity of hepatitis C virus envelope glycoprotein complex by high-throughput mutagenesis
por: Gopal, Radhika, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_0oj8s0hdt0mqm99uad36fuso3n